Didier Dréau earned a Bachelor of Science in Physiology and Cell Biology from Rennes I University (Rennes, France), a Master of Science in Molecular and Cell Biology from Blaise Pascal University (Clermont-Ferrand, France), and a Ph.D. in Biochemistry, Molecular and Cell Biology with emphasis on immunology from the Ecole Nationale Supérieure Agronomique (ENSA) de Rennes (France).
Following postdoctoral training in immunology and immunotherapy, Dréau served as research scientist at Carolinas Medical Center (Charlotte, NC). Currently, he is an associate professor of biology and director of Undergraduate Research, the Honors in Biological Sciences Program director in the Department of Biological Sciences and the area leader for the Applied Cancer Technology and Therapeutics in the Center for Biomedical Engineering and Science.
In addition to his teaching of cancer biology and physiology, Dréau, a member of the American Association for Cancer Research, serves on multiple granting agency review panels along with scientific journal editorial boards. The focus of the research developed in his laboratory is on angiogenesis, immune responses and the physical and chemical tumor microenvironment in the promotion of metastasis. His research efforts include dedicated interests in the development of new approaches to prevention, early detection, monitoring and treatment of cancers.